EX-99.1 2 d571547dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO    3560 Bassett Street, Santa Clara CA 95054        

 

Jeff Andreson      Claire McAdams
Chief Financial Officer      Investor Relations
(408) 986-9888      (530) 265-9899

INTEVAC ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS

Santa Clara, Calif.—July 29, 2013—Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the quarter and six months ended June 29, 2013.

In a challenging business environment, we are encouraged by several positive recent announcements for Intevac,” commented Norman Pond, Chairman. “In our equipment business, we received orders for three 200 Lean systems and completed qualification and recognized revenue for our first production solar implant system. In our Photonics business, we were awarded a $27 million contract from the U.S. Army for the Apache helicopter, which resulted in a record $48 million of Photonics backlog at quarter end, which will drive our revenue growth for Photonics in 2014.

“As we announced earlier this month, Mr. Wendell Blonigan joined us as president and chief executive officer and I will continue as chairman of the board of directors. Wendell has a demonstrated track record of success managing high-technology equipment businesses and bringing innovative products to market. We welcome Wendell to his new role and look forward to working with him.”

 

($ Millions, except per share amounts)    Q2 2013     Q2 2012  
     GAAP Results     Non-GAAP Results     GAAP Results     Non-GAAP Results  

Net Revenues

   $ 17.0      $ 17.0      $ 31.8      $ 31.8   

Operating Loss

   $ (7.0   $ (6.8   $ (0.7   $ (0.7

Net Loss

   $ (6.4   $ (6.2   $ (1.5   $ (1.5

Net Loss per Share

   $ (0.27   $ (0.26   $ (0.06   $ (0.06

 

     Six Months Ended     Six Months Ended  
     June 29, 2013     June 30, 2012  
     GAAP Results     Non-GAAP Results     GAAP Results     Non-GAAP Results  

Net Revenues

   $ 30.0      $ 30.0      $ 49.1      $ 49.1   

Operating Loss

   $ (16.0   $ (15.1   $ (7.6   $ (9.8

Net Loss

   $ (14.7   $ (13.8   $ (4.7   $ (6.3

Net Loss per Share

   $ (0.62   $ (0.58   $ (0.20   $ (0.27

Second Quarter 2013 Summary

The net loss for the quarter was $6.4 million, or $0.27 per share, compared to a net loss of $1.5 million, or $0.06 per share, in the second quarter of 2012. The non-GAAP net loss for the second quarter of 2013 excludes a $0.2 million restructuring charge and was $6.2 million or $0.26 per share.


Revenues were $17.0 million, including $9.2 million of Equipment revenues and Intevac Photonics revenues of $7.8 million. Equipment revenues included one solar implant ENERGi™ system, upgrades, spares and service. Intevac Photonics revenues consisted of $3.7 million of research and development contracts and $4.1 million of product sales. In the second quarter of 2012, revenues were $31.8 million, including $25.1 million of Equipment revenues and Intevac Photonics revenues of $6.7 million, which included $3.2 million of research and development contracts.

Equipment gross margin was 14.8% compared to 47.1% in the second quarter of 2012 and 22.4% in the first quarter of 2013. The decrease compared to the prior quarter was primarily due to a refurbishment reserve recorded for a solar evaluation system shipped in 2012, as well as the lower margin on the first solar implant ENERGi system recognized for revenue. These factors similarly contributed to the year-on-year gross margin decline, which also reflects the lower level of revenue from systems and upgrades, and lower factory absorption. We did not recognize revenue on any 200 Lean systems in the first or second quarter of 2013 compared to two systems in the second quarter of 2012.

Intevac Photonics gross margin was 31.7% compared to 36.3% in the second quarter of 2012 and 30.4% in the first quarter of 2013. The reduction from the second quarter of 2012 was driven by lower margins on our technology development programs. The improvement from the first quarter of 2013 was a result of improved yields for our low-light sensor. Consolidated gross margin was 22.5%, compared to 44.8% in the second quarter of 2012 and 27.1% in the first quarter of 2013.

Operating expenses of $10.8 million declined 12% compared to the first quarter of 2013, reflecting savings from our global cost reduction plan as well as further reductions made during the quarter. The operating loss for the second quarter of 2013 includes $0.2 million in associated restructuring charges.

Order backlog totaled $77.6 million on June 29, 2013, compared to $35.1 million on March 30, 2013 and $43.3 million on June 30, 2012. Backlog as of June 29, 2013 includes three 200 Lean® systems. Backlog at March 30, 2013 included one ENERGi Solar system and no 200 Lean systems. Backlog as of June 30, 2012 did not include any 200 Lean systems or Solar systems.

The Company ended the quarter with $88.3 million of cash and investments and $124.6 million in tangible book value.

First Six Months 2013 Summary

The net loss was $14.7 million, or $0.62 per share, compared to a net loss of $4.7 million, or $0.20 per share, for the first six months of 2012. The non-GAAP net loss, which excludes a $0.7 million restructuring charge and a $0.2 million divestiture loss, was $13.8 million or $0.58 per share. This compares to the first half 2012 non-GAAP net loss of $6.3 million, or $0.27 per share, which excludes a $2.2 million divestiture gain.

Revenues were $30.0 million, including $14.5 million of Equipment revenues and Intevac Photonics revenues of $15.4 million, compared to revenues of $49.1 million, including $35.8 million of Equipment revenues and Intevac Photonics revenues of $13.3 million, for the first six months of 2012.

Equipment gross margin was 17.6%, compared to 46.5% in the first six months of 2012, primarily due to the lower level of revenue from systems and upgrades, lower factory absorption, a refurbishment provision for a solar evaluation system, and the lower system


margin on the first solar implant ENERGi system recognized for revenue. We did not recognize revenue on any 200 Lean systems in the first half of 2013 compared to two systems in the first half of 2012. Intevac Photonics gross margin was 31.0% compared to 33.2% in the first six months of 2012, reflecting lower margins on our technology development programs. Consolidated gross margin was 24.5%, compared to 42.9% in the first six months of 2012.

Operating expenses were $23.1 million, which includes approximately $0.4 million in severance costs related to our global cost reduction plan, and were down 25% from $30.9 million in the first six months of 2012. The operating loss of $16.0 million included a total of $0.7 million of restructuring charges and a $0.2 million loss on the sale of our Raman spectroscopy product line. The operating loss of $7.6 million for the first six months of 2012 included a $2.2 million gain on the sale of our mainframe technology.

Use of Non-GAAP Financial Measures

Intevac’s non-GAAP results exclude the impact of the following, where applicable: (1) restructuring charges; and (2) gains or losses on sales of product lines and technology assets. A reconciliation of the GAAP and non-GAAP results is provided in the financial tables included in this release.

Management uses non-GAAP results to evaluate the company’s operating and financial performance in light of business objectives and for planning purposes. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. Intevac believes these measures enhance investors’ ability to review the company’s business from the same perspective as the company’s management and facilitate comparisons of this period’s results with prior periods. The presentation of this additional information should not be considered a substitute for results prepared in accordance with GAAP.

Conference Call Information

The company will discuss its financial results and outlook in a conference call today at 1:30 p.m. PDT (4:30 p.m. EDT). To participate in the teleconference, please call toll-free (877) 334-0811 prior to the start time. For international callers, the dial-in number is (408) 427-3734. You may also listen live via the Internet at the company’s website, www.intevac.com, under the Investors link, or at www.earnings.com. For those unable to attend, these web sites will host an archive of the call. Additionally, a telephone replay of the call will be available for 48 hours beginning today at 7:30 p.m. EDT. You may access the replay by calling (855) 859-2056 or, for international callers, (404) 537-3406, and providing Replay Passcode 10644699.

About Intevac

Intevac was founded in 1991 and has two businesses: Equipment and Intevac Photonics.

In our Equipment business, we are a leader in the design, development and manufacturing of high-productivity, vacuum process equipment solutions. Our systems are production-proven for high-volume manufacturing of small substrates with precise thin film properties, such as those required in the hard drive and solar cell markets we currently serve.

In the hard drive industry, our 200 Lean® systems process approximately 60% of all magnetic disk media produced worldwide. In the solar cell manufacturing industry, our LEAN SOLAR™ systems increase the conversion efficiency of silicon solar cells.


In our Photonics business, we are a leader in the development and manufacture of leading-edge, high-sensitivity imaging products and vision systems. Our products primarily address the defense markets.

For more information call 408-986-9888, or visit the company’s website at www.intevac.com.

200 Lean® is a registered trademark and ENERGi™ and LEAN SOLAR™ are trademarks of Intevac, Inc.

Safe Harbor Statement

This press release includes statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Intevac claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms “may,” “believes,” “projects,” “expects,” or “anticipates,” and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: expected delivery of cameras for the Apache program, and the continued revenue and profitability growth of Photonics. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the company’s expectations. These risks include, but are not limited to: oversupply in the media industry, a further slowdown in demand for hard drives, a change in the delivery rate of the cameras for the Apache program and the failure to ship these cameras, each of which could have a material impact on our business, our financial results, and the company’s stock price. These risks and other factors are detailed in the company’s periodic filings with the U.S. Securities and Exchange Commission.


INTEVAC, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in thousands, except per share amounts)

 

     Three months ended     Six months ended  
     June 29,
2013
    June 30,
2012
    June 29,
2013
    June 30,
2012
 

Net revenues

        

Equipment

   $ 9,164      $ 25,059      $ 14,532      $ 35,778   

Intevac Photonics

     7,819        6,732        15,433        13,329   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net revenues

     16,983        31,791        29,965        49,107   

Gross profit

     3,829        14,254        7,343        21,078   

Gross margin

        

Equipment

     14.8     47.1     17.6     46.5

Intevac Photonics

     31.7     36.3     31.0     33.2
  

 

 

   

 

 

   

 

 

   

 

 

 

Consolidated

     22.5     44.8     24.5     42.9

Operating expenses

        

Research and development

     5,584        8,263        11,943        17,476   

Selling, general and administrative

     5,235        6,669        11,206        13,442   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     10,819        14,932        23,149        30,918   

Gain (loss) on divestitures

     —          —          (208     2,207   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating loss

     (6,990     (678     (16,014     (7,633

Income/(Loss) from operations

        

Equipment

     (5,841     1,129        (13,183     (5,196

Intevac Photonics

     253        (616     62        (1,656

Corporate1,2

     (1,402     (1,191     (2,893     (781
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating loss

     (6,990     (678     (16,014     (7,633

Interest and other income

     92        48        172        420   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (6,898     (630     (15,842     (7,213

Provision for (benefit from) income taxes

     (486     863        (1,166     (2,559
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (6,412   $ (1,493   $ (14,676   $ (4,654
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss per share

        

Basic and Diluted

   $ (0.27   $ (0.06   $ (0.62   $ (0.20

Weighted average common shares outstanding

        

Basic and Diluted

     23,785        23,265        23,724        23,241   

 

1

Six months ended June 29, 2013 includes the loss on sale of the Raman spectroscopy product line of $208,000.

2

Six months ended June 30, 2012 includes the gain on sale of the mainframe technology of $2.2 million.


INTEVAC, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value)

 

     June 29,
2013
    December 31,
2012
 
     (Unaudited)     (see Note)  

ASSETS

  

Current assets

  

Cash, cash equivalents and short-term investments

   $ 68,594      $ 64,852   

Accounts receivable, net

     17,542        19,822   

Inventories

     25,625        26,193   

Prepaid expenses and other current assets

     1,289        2,120   
  

 

 

   

 

 

 

Total current assets

     113,050        112,987   

Long-term investments

     19,701        27,317   

Property, plant and equipment, net

     12,328        13,426   

Deferred income tax assets

     13,500        12,176   

Intangible assets, net

     5,459        5,868   

Other long-term assets

     614        729   
  

 

 

   

 

 

 

Total assets

   $ 164,652      $ 172,503   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

  

Current liabilities

  

Accounts payable

   $ 6,491      $ 4,479   

Accrued payroll and related liabilities

     4,663        4,194   

Deferred income tax liabilities

     1,281        1,281   

Other accrued liabilities

     4,520        8,489   

Customer advances

     8,317        2,193   
  

 

 

   

 

 

 

Total current liabilities

     25,272        20,636   

Other long-term liabilities

     9,328        9,232   

Stockholders’ equity

  

Common stock ($0.001 par value)

     24        23   

Additional paid in capital

     154,187        151,996   

Accumulated other comprehensive income

     670        769   

Accumulated deficit

     (24,829     (10,153
  

 

 

   

 

 

 

Total stockholders’ equity

     130,052        142,635   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 164,652      $ 172,503   
  

 

 

   

 

 

 

Note: Amounts as of December 31, 2012 are derived from the December 31, 2012 audited consolidated financial statements.


INTEVAC, INC.

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

(Unaudited, in thousands, except per share amounts)

 

     Three months ended     Six months ended  
     June 29,
2013
    June 30,
2012
    June 29,
2013
    June 30,
2012
 

Non-GAAP Loss from Operations

        

Reported operating loss (GAAP basis)

   $ (6,990   $ (678   $ (16,014   $ (7,633

Restructuring charges1

     240        —          742        —     

Loss on sale of Raman spectroscopy product line2

     —          —          208        —     

Gain on sale of mainframe technology3

     —          —          —          (2,207
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Operating Loss

   $ (6,750   $ (678   $ (15,064   $ (9,840
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Net Loss

        

Reported net loss (GAAP basis)

   $ (6,412   $ (1,493   $ (14,676   $ (4,654

Restructuring charges1

     240        —          742        —     

Loss on sale of Raman spectroscopy product line2

     —          —          208        —     

Gain on sale of mainframe technology3

     —          —          —          (2,207

Income tax effect of non-GAAP adjustments4

     (20     —          (42     554   
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Net Loss

   $ (6,192   $ (1,493   $ (13,768   $ (6,307
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Loss Per Diluted Share

        

Reported loss per diluted share (GAAP basis)

   $ (0.27   $ (0.06   $ (0.62   $ (0.20

Restructuring charges1

     0.01        —          0.03        —     

Loss on sale of Raman spectroscopy product line2

     —          —          0.01        —     

Gain on sale of mainframe technology3

     —          —          —          (0.07
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Loss Per Diluted Share

   $ (0.26   $ (0.06   $ (0.58   $ (0.27
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of diluted shares

     23,785        23,265        23,724        23,241   

 

1

Results for the three and six months ended June 29, 2013 include severance and other employee-related costs of $240,000 and $742,000, respectively related to the restructuring program announced on February 1, 2013.

2 

The six months ended June 29, 2013 includes the loss on sale of the Raman spectroscopy product line of $208,000. On March 29, 2013, the Company sold certain assets including tangible and intangible assets and divested of certain liabilities which comprised its Raman spectroscopy product line for proceeds of not to exceed $1.5 million of which $500,000 was paid in cash upon closing and up to $1.0 million is in the form of an earnout. Intevac did not recognize the earnout payments upon closing given the uncertainties associated with the achievement of the earnout.

3 

The six months ended June 30, 2012 includes the gain on sale of the mainframe technology of $2.2 million. On January 6, 2012, the Company sold certain assets including intellectual property and residual assets which comprised its semiconductor mainframe technology for proceeds of $3.0 million.

4 

The amount represents the estimated income tax effect of the non-GAAP adjustments. The Company calculated the tax effect of non-GAAP adjustments by applying an applicable estimated jurisdictional tax rate to each specific non-GAAP item.